CLINICAL_TRIALS
trial_result
· 2022-02-10
Clinical Trial Update: Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer [Phase 2]
Summary
Phase 2 trial update for pembrolizumab in anaplastic thyroid cancer has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Saad A Khan | Conditions: Anaplastic Thyroid Cancer | Phase 2 | Status: COMPLETED | Results posted: 2022-02-10